Generics Savings Once Again Could Help A Major Health Care Reform Bill

A provision in the pending legislation on PBMs that would allow the US FDA to provide qualitative and quantitative information to ANDA sponsors about reference product's inactive ingredients could save hundreds of millions in spending.

savings
Drug savings played a significant role in reducing the budget deficit in the CBO score of the House PBM reform bill. • Source: Shutterstock

Once again, a provision intended to help speed generic drug market access would command substantial savings in pending legislation.

HR 5378, a House Republican bill intended to reform the pharmacy benefit manager system and make other changes, also...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet